RhumbLine Advisers’s Orchestra BioMed OBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-31,657
| Closed | -$135K | – | 4224 |
|
|
2025
Q1 | $135K | Buy |
31,657
+914
| +3% | +$3.91K | ﹤0.01% | 3285 |
|
|
2024
Q4 | $123K | Buy |
30,743
+1,196
| +4% | +$4.78K | ﹤0.01% | 3415 |
|
|
2024
Q3 | $152K | Buy |
29,547
+3,108
| +12% | +$16K | ﹤0.01% | 3362 |
|
|
2024
Q2 | $215K | Buy |
26,439
+17,405
| +193% | +$142K | ﹤0.01% | 3191 |
|
|
2024
Q1 | $47.6K | Buy |
9,034
+606
| +7% | +$3.19K | ﹤0.01% | 3635 |
|
|
2023
Q4 | $76.9K | Buy |
8,428
+874
| +12% | +$7.98K | ﹤0.01% | 3526 |
|
|
2023
Q3 | $65.9K | Buy |
7,554
+4,379
| +138% | +$38.2K | ﹤0.01% | 3585 |
|
|
2023
Q2 | $22.2K | Buy |
+3,175
| New | +$22.2K | ﹤0.01% | 3797 |
|